Remacemide is a low-affinity NMDA antagonist with sodium channel blocking properties. It has been studied for the treatment of acute ischemic stroke, epilepsy, Huntingtons disease, and Parkinsons disease.
Molecular Weight:
268.35
CAS Number:
[128298-28-2]
Formula:
C17H20N2O
Target:
iGluR|||Others
T71969
* VAT and and shipping costs not included. Errors and price changes excepted